RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bharat Parenterals - Stock

Bharat Parenterals ROE 2024

Bharat Parenterals ROE

0.07

Ticker

541096.BO

ISIN

INE365Y01019

In 2024, Bharat Parenterals's return on equity (ROE) was 0.07, a -42.04% increase from the 0.13 ROE in the previous year.

Bharat Parenterals Aktienanalyse

What does Bharat Parenterals do?

Bharat Parenterals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Bharat Parenterals's Return on Equity (ROE)

Bharat Parenterals's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Bharat Parenterals's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Bharat Parenterals's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Bharat Parenterals’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Bharat Parenterals Stock

What is the ROE (Return on Equity) of Bharat Parenterals this year?

The ROE of Bharat Parenterals this year is 0.07 undefined.

How has the Return on Equity (ROE) of Bharat Parenterals developed compared to the previous year?

The ROE of Bharat Parenterals has increased by -42.04% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Bharat Parenterals?

A high ROE indicates that Bharat Parenterals generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Bharat Parenterals?

A low ROE can indicate that Bharat Parenterals is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Bharat Parenterals affect the company?

A change in ROE (Return on Equity) of Bharat Parenterals can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Bharat Parenterals?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Bharat Parenterals?

Some factors that can influence Bharat Parenterals's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Bharat Parenterals pay?

Over the past 12 months, Bharat Parenterals paid a dividend of 0.75 INR . This corresponds to a dividend yield of about 0.05 %. For the coming 12 months, Bharat Parenterals is expected to pay a dividend of 0.75 INR.

What is the dividend yield of Bharat Parenterals?

The current dividend yield of Bharat Parenterals is 0.05 %.

When does Bharat Parenterals pay dividends?

Bharat Parenterals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bharat Parenterals?

Bharat Parenterals paid dividends every year for the past 0 years.

What is the dividend of Bharat Parenterals?

For the upcoming 12 months, dividends amounting to 0.75 INR are expected. This corresponds to a dividend yield of 0.05 %.

In which sector is Bharat Parenterals located?

Bharat Parenterals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bharat Parenterals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bharat Parenterals from 10/29/2023 amounting to 0.75 INR, you needed to have the stock in your portfolio before the ex-date on 9/25/2023.

When did Bharat Parenterals pay the last dividend?

The last dividend was paid out on 10/29/2023.

What was the dividend of Bharat Parenterals in the year 2023?

In the year 2023, Bharat Parenterals distributed 0 INR as dividends.

In which currency does Bharat Parenterals pay out the dividend?

The dividends of Bharat Parenterals are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bharat Parenterals

Our stock analysis for Bharat Parenterals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bharat Parenterals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.